# Optimal Injection Interval for Intra-Detrusor Botulinum Toxin

> **NCT06483217** · NA · NOT_YET_RECRUITING · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 100 (estimated)

## Conditions studied

- Overactive Bladder
- Urinary Urgency
- Urinary Incontinence
- Urge Urinary Incontinence

## Interventions

- **BEHAVIORAL:** Patient-directed follow up

## Key facts

- **NCT ID:** NCT06483217
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2025-07
- **Final completion:** 2025-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06483217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06483217, "Optimal Injection Interval for Intra-Detrusor Botulinum Toxin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06483217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*